United Therapeutics CEO Martine A. Rothblatt disposes of shares worth $4,287,172.85

Bitget2026/09/30 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

United Therapeutics Chairperson and CEO Martine A. Rothblatt reported option exercise and stock sales on Sept. 29, 2026.
Family trust acquired 9,500 shares at USD 117.76 via stock option exercise.
Trust sold 9,500 shares at prices from USD 472.0452 to USD 486.77.
Trust-held common stock position ended at 324,443 shares.
Trust-held stock options ended at 337,910 options, exercisable at USD 117.76.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000152), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

United Therapeutics CEO Martine A. Rothblatt disposes of shares worth $4,287,172.85

You may also like

Crypto prices